Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Luxdegalutamide (ARV-766) is an orally available and effective protein degrader of protein hydrolysis-targeted chimeras (PROTAC).Luxdegalutamide degrades the wild-type androgen receptor AR, as well as AR LBD mutants including those associated with the most prevalent pathogenic AR L702H, H875Y and T878A mutations.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 73,500 |
5 mg | 在庫あり | ¥ 176,500 |
10 mg | 在庫あり | ¥ 271,000 |
25 mg | 在庫あり | ¥ 496,000 |
50 mg | 在庫あり | ¥ 649,500 |
100 mg | 在庫あり | ¥ 870,000 |
説明 | Luxdegalutamide (ARV-766) is an orally available and effective protein degrader of protein hydrolysis-targeted chimeras (PROTAC).Luxdegalutamide degrades the wild-type androgen receptor AR, as well as AR LBD mutants including those associated with the most prevalent pathogenic AR L702H, H875Y and T878A mutations. |
別名 | ARV-766 |
分子量 | 807.95 |
分子式 | C45H54FN7O6 |
CAS No. | 2750830-09-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Luxdegalutamide 2750830-09-0 Endocrinology/Hormones PROTAC Androgen Receptor PROTACs ARV-766 ARV 766 ARV766 Inhibitor inhibitor inhibit